Repetitive mild traumatic brain injury affects inflammation and excitotoxic mRNA expression at acute and chronic

Matthew I Hiskens1,2, Anthony G Schneiders1, Rebecca K Vella1

  • 1School of Health, Medical and Applied Sciences, Central Queensland University, Rockhampton, Queensland, Australia.

Plos One
|May 7, 2021
PubMed

Insights

Repeated mild traumatic brain injuries (mTBI) cause chronic neurological damage, impairing spatial memory and altering gene expression in the brain. These findings highlight molecular targets for future mTBI therapies.

Area of Science:

  • Neuroscience
  • Neurology
  • Molecular Biology

Background:

  • Mild traumatic brain injury (mTBI) can lead to cumulative neurological damage.
  • The molecular mechanisms behind mTBI-induced detriment require further elucidation.

Purpose of the Study:

  • To investigate the acute and chronic outcomes of single and repeated mTBIs.
  • To explore the molecular mechanisms underlying mTBI pathophysiology.

Main Methods:

  • A closed head weight drop model was used in adult male mice.
  • Mice received one, five, or 15 impacts over 23 days.
  • Spatial learning and memory were assessed, alongside mRNA analysis of brain tissue and serum protein levels.

Main Results:

  • Impaired spatial learning and memory were observed in the 15-impact group, persisting from acute to chronic phases.
  • Upregulation of excitotoxicity and inflammation genes (MAPT, GFAP, AIF1, GRIA1, CCL11, TARDBP, TNF, NEFL) was noted in the cortex and hippocampus.
  • No significant differences in serum phosphorylated tau or GFAP levels were found between groups.

Conclusions:

  • Cumulative mTBI impacts are sufficient to induce mTBI pathophysiology and clinical features.
  • Investigated genes offer potential targets for understanding mTBI neuropathology.
  • These genes may serve as therapeutic targets for mitigating mTBI effects.

Related Concept Videos